The burden of Pseudomonas aeruginosa infections in Iraq: A review | ||||
| Microbes and Infectious Diseases | ||||
| Articles in Press, Accepted Manuscript, Available Online from 12 August 2025 | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/mid.2025.407682.3054 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Yasmeen Kateb Ahmed  ; Mustafa Jaber Hamadailla
| ||||
| Department of Medical Laboratories Techniques, College of Health and Medical Technology, University of Al Maarif, Al Anbar,31001, Iraq | ||||
| Abstract | ||||
| Background: Pseudomonas aeruginosa is a multidrug-resistant pathogen that poses significant healthcare challenges, especially in low- and middle-income countries (LMICs) such as Iraq. Infections caused by P. aeruginosa, including urinary tract infections, bloodstream infections, and pneumonia, are increasingly prevalent in Iraqi healthcare facilities. The P. aeruginosa ability to develop resistance to various antibiotics, including carbapenems, has made treatment challenging, contributing to high morbidity and mortality rates. Furthermore, poor infection control measures and limited diagnostic capabilities heighten the spread of these infections in hospitals. This review aims to investigate the severity, and burden of P. aeruginosa infections in Iraq, exploring the prevalence of nosocomial infections as well as the challenges posed by antimicrobial resistance. The review also discusses the urgent need for effective antimicrobial stewardship programs and improved infection prevention strategies to alleviate the burden of P. aeruginosa infections in Iraq. Finally, review provides information needed to enhance surveillance systems to better understand for addressing the growing threat of antimicrobial resistance in the region. | ||||
| Keywords | ||||
| Pseudomonas aeruginosa; antimicrobial resistance; hospital-acquired infections; healthcare-associated infections; carbapenem resistance | ||||
|
Statistics Article View: 12 |
||||
